Promoter holding
64.27%
VL
Viyash Life Sciences Private Limited - Due diligence report
A 360° intelligence report on Viyash: trust score, financial health, credit view, compliance, directors, growth and distress signals - gener…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Viyash — 360° Intelligence Report
Generated from MCA filings & public records61/100
Trust Score
Moderate
Viyash is assessed as Moderate with a Trust Score of 61/100. Viyash is a private limited indian non-government company incorporated in 2019, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and moderate financial risk profile.
Report generated on 16 Jul 2026 from the latest processed filings. Viyash Life Sciences Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
61/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
41/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
65/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
70/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
50/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Consolidated · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 70/100 Moderate
- Moderate gearing (D/E 38%).
- Working-capital cover adequate.
Charges position: 8 open (43.74 cr) · 0 satisfied (-).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 8 | 48.0 cr |
Compliance Score: 41/100 Caution Indicated
- Company status is "Amalgamated" - not Active.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 2 court forum(s).
- 3 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 85/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| HARI BABU BODEPUDI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUNIL KAUL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PRADIP MANILAL KANAKIA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KALIDINDI SRIHARI RAJU | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KAMAL KISHORE SHARMA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| JANAKI SEETHANABOINA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| GURVEEN SINGH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ANUJ VISHNUKUMAR PODDAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| AMIT JAIN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| HARI BABU BODEPUDI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 10 directors on the board.
- No disqualified or deactivated DINs.
- 3 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2025)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
4
Group entities
4
Capital events
16 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Appcure Labs Private Limited | Subsidiary Company | 74.00% |
| Vandana Life Sciences Private Limited | Subsidiary Company | 74.00% |
| Vindhya Pharma (india) Private Limited | Subsidiary Company | 74.00% |
| Symed Labs Limited | Subsidiary Company | 74.00% |
| Appco Pharma Llc | Subsidiary Company | 74.00% |
Key managerial personnel: HARI BABU BODEPUDI (CEO) · KALIDINDI SRIHARI RAJU (Whole-time director) · HARI BABU BODEPUDI (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 70 · Distress 50
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Operating for 7 years.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
Adverse company status: Amalgamated.
Compliance score is weak (41/100).
8 open charge(s) registered - assets are encumbered.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence50/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment61/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 8 open charge(s) of 43.74 cr already registered.
- Compliance gaps should be priced into terms.
Investor view66/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 1 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events04 Oct 2025
Charge created
Hdfc Bank Limited - 38.92 Lakh
25 Sep 2025
Charge created
Hdfc Bank Limited - 17.54 Lakh
18 Jul 2025
Last AGM held
Annual general meeting
17 Jul 2025
Director ceased
ANUJ VISHNUKUMAR PODDAR
31 Mar 2025
Latest balance sheet
Filed with ROC
05 Mar 2025
Charge created
Hdfc Bank Limited - 24.64 Lakh
28 Jan 2025
Charge created
Hdfc Bank Limited - 7.49 cr
13 Nov 2024
Director appointed
ANUJ VISHNUKUMAR PODDAR (Director)
29 Sep 2023
Director ceased
TARUN GARG
29 Aug 2023
Director ceased
CHRISTOPHER MICHAEL CONWAY
04 Jan 2023
Director appointed
SUNIL KAUL (Nominee Director)
Director appointed
AMIT JAIN (Nominee Director)
26 Dec 2022
Director ceased
KAMAL KISHORE SHARMA
01 Dec 2022
Director appointed
KAMAL KISHORE SHARMA (Director)
Director ceased
RAHUL NIRMAL MUKIM
10
Key Observations
Auto-generated from the data aboveRevenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - manageable leverage.
Net worth is positive.
10 active director(s) / partner(s); board looks stable and experienced.
3 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 4 subsidiary(ies) - assess on a consolidated basis.
Promoters hold a dominant controlling stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 16 security allotment(s) - amounts available in the full report.
1 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Nestorpharma | U24231DL1975PLC007959 | New Delhi, Delhi, India |
| Paushak | L51909GJ1972PLC044638 | Vadodara, Gujarat, India |
| Ambey Iron Private Limited | U13100GA2003PTC003274 | Panaji, Goa, India |
| Beta Drugs | L24230HP2005PLC028969 | Baddi, Himachal Pradesh, India |
| Sequent | L99999TS1985PLC196357 | Shaikpet, Telangana, India |
| Sanginita Chemicals | L24100GJ2005PLC047292 | Gujarat, Gujarat, India |
| Agastya Agro | U01122TG1995PLC019729 | Andhra Pradesh, Telangana, India |
| Ganesh | L24200MH1986PLC039836 | Mumbai, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Viyash before audits and certifications: compliance score 41/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Viyash: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 70/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 70/100, margin trends, ownership structure and peer set for Viyash - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 61/100, distress signals and MSME payment-delay disclosures - know whether Viyash pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Viyash - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Viyash an active company?
Viyash has MCA status “Amalgamated” with a compliance score of 41/100 (Caution Indicated).
Is Viyash financially healthy?
Viyash has a Financial Health Score of 65/100 (Moderate) based on its filed financial statements.
Should I do business with Viyash?
Its overall Trust Score is 61/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Viyash?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 10 active director(s) are on record.
Does Viyash have loans or charges against its assets?
8 open charge(s) are registered against its assets.
Is Viyash up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 41/100 (Caution Indicated).
Is it risky to lend to Viyash?
Its Credit Risk Score is 70/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
